Addressing psoriasis from Internal Medicine and Dermatology: Current Strategies for Comprehensive Treatment
DOI:
https://doi.org/10.55204/trc.v3i2.e277Keywords:
Psoriasis, Pustular Psoriasis, diagnosis, treatmentAbstract
Introduction: Psoriasis is a chronic inflammatory disease characterized by thick, well-demarcated erythematous plaques, along with overlapping silvery scales. The severity of the disease varies widely, with some patients experiencing only a dermal plaque while others experience systemic disease. Patients with psoriasis also have an impact on their quality of life that affects their psychosocial environment.
Development: An article reviewing the documents of scientific societies dedicated to the diagnosis and treatment of psoriasis in adults was carried out, as well as systematic reviews and current scientific studies in SCOPUS, WOS and Pubmed and Google Scholar in both Spanish and English.
Practical applications or future lines of research: An AI system is currently being developed for the evaluation of the severity of psoriasis using neural networks to improve the diagnosis of the severity of psoriasis.
Conclusions: Psoriasis is a chronic inflammatory dermatosis mediated by a response especially mediated by the adaptive immune system. There are risk factors associated with psoriasis like cardiovascular risk factors. Psoriasis comprises a wide range of clinical manifestations from simple scaly erythematous plaques to life-threatening systemic diseases. The fundamental pillar of psoriasis treatment is based on the degree of involvement of the clinical manifestations.
Downloads
References
Brandon A, Mufti A, Gary Sibbald R. Diagnosis and Management of Cutaneous Psoriasis: A Review. Adv Skin Wound Care. 2019;32(2):58. doi:10.1097/01.ASW.0000550592.08674.43
Papp KA, Gooderham MJ, Lynde CW, et al. Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology. Dermatol Ther. 2022;12(1):253-265. doi:10.1007/s13555-021-00642-5
Sharma J, Daman R. Molecular Analysis, Pathophysiology, and Drug Delivery Mechanism with Reference to Psoriasis: A Review. Orient J Chem. 2022;38(4):940-947. doi:http://dx.doi.org/10.13005/ojc/380415
Sousa B, Pereira TG, Pires P. Under my Skin: The Psychosocial Dimension of Psoriasis. Acta Médica Port. 2023;36(6):449-450. doi:10.20344/amp.19564
Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020;323(19):1945-1960. doi:10.1001/jama.2020.4006
Papp KA, Gniadecki R, Beecker J, et al. Psoriasis Prevalence and Severity by Expert Elicitation. Dermatol Ther. 2021;11(3):1053-1064. doi:10.1007/s13555-021-00518-8
Fernández-Armenteros JM, Gómez-Arbonés X, Buti-Solé M, et al. Epidemiology of Psoriasis. A Population-Based Study. Actas Dermo-Sifiliográficas Engl Ed. 2019;110(5):385-392. doi:10.1016/j.adengl.2019.01.014
Fernández-Ávila DG, Charry Anzola LP, González-Cardona LP. Prevalencia de psoriasis en Colombia según datos del Registro Nacional en Salud. Actas Dermo-Sifiliográficas. 2022;113(3):339-341. doi:10.1016/j.ad.2020.09.015
Danielsen K, Duvetorp A, Iversen L, et al. Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis. Acta Derm Venereol. 2019;99(1):18-25. doi:10.2340/00015555-3017
Dures E, Bowen C, Brooke M, et al. Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients. Rheumatol Adv Pract. 2019;3(2):rkz022. doi:10.1093/rap/rkz022
Ali Rida M, Chandran V. Challenges in the clinical diagnosis of psoriatic arthritis. Clin Immunol. 2020;214:108390. doi:10.1016/j.clim.2020.108390
Hioki T, Komine M, Ohtsuki M. Diagnosis and Intervention in Early Psoriatic Arthritis. J Clin Med. 2022;11(7):2051. doi:10.3390/jcm11072051
Yaylı S. Topical therapies. TURKDERM. Published online May 5, 2022:6-9. doi:10.4274/turkderm.galenos.2022.68638
Sadowska M, Lesiak A, Narbutt J. Application of phototherapy in the treatment of psoriasis vulgaris. Dermatol Rev Dermatol. 2019;106(2):198-209. doi:10.5114/dr.2019.85577
Saeki H, Mabuchi T, Asahina A, et al. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). J Dermatol. 2023;50(2):e41-e68. doi:10.1111/1346-8138.16691
Ghafoor R, Patil A, Yamauchi P, et al. Treatment of Scalp Psoriasis. J Drugs Dermatol. 2022;21(8):833-837. doi:10.36849/JDD.6498
Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse Psoriasis: From Diagnosis to Current Treatment Options. Clin Cosmet Investig Dermatol. 2020;Volume 12:953-959. doi:10.2147/CCID.S189000
Lo Y, Tsai TF. Updates on the Treatment of Erythrodermic Psoriasis. Psoriasis Targets Ther. 2021;11:59-73. doi:10.2147/PTT.S288345
Fujita H, Gooderham M, Romiti R. Diagnosis of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022;23(1):31-38. doi:10.1007/s40257-021-00652-1
Development of the Generalized Pustular Psoriasis Clinical Assessment Tool. J Am Acad Dermatol. Published online September 20, 2023. doi:10.1016/j.jaad.2023.08.096
Rivera-Díaz R, Daudén E, Carrascosa JM, Cueva P de la, Puig L. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment. Dermatol Ther. 2023;13(3):673-688. doi:10.1007/s13555-022-00881-0
LB1036 Artificial intelligence for the automated assessment of psoriasis severity. J Invest Dermatol. 2022;142(8):B37. doi:10.1016/j.jid.2022.05.1074
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Samantha Vanessa Piedra Bravo, Erik Manuel Cushpa Quinapanta, María José Clavijo Quizhpilema, Liliana Katherine León Ruiz, Ana Verónica Cruz Andrade, Gregorio Alexander Mendoza Ocampo, Victor Andres Gómez Leiva
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
